Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hemodynamic Optimization with Perioperative Gold Directed Therapy (PGDT) in Kidney Transplant

NCT05035537 is registered in ClinicalTrials.gov with IRCCS Azienda Ospedaliero-Universitaria di Bologna as lead sponsor.

NCT NCT05035537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05035537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hemodynamic Optimization with Perioperative Gold Directed Therapy (PGDT) in Kidney Transplant
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2018
Completion date
November 30, 2023
Enrollment
181 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

complications, kidney transplant